Vertex Pharmaceuticals Inc
NASDAQ: VRTX
$484.24
+$3.91 (+0.8%)
Closing Price on February 21, 2025
VRTX Articles
Goldman Sachs has seven biopharma stocks on its Conviction Buy list, and these are not all coronavirus plays. The firm thinks these stocks could go on the offensive for the rest of the year.
Published:
Wednesday's top analyst upgrades and downgrades included Altria, Apple, Caterpillar, Citigroup, JPMorgan, Nikola, Nokia, Novavax, Transocean, Valero Energy, Walt Disney and Wells Fargo.
Published:
Tuesday's top analyst upgrades and downgrades included Beyond Meat, BioNTech, Comcast, DraftKings, Expedia, Gap, Gilead Sciences, Hess, Lululemon Athletica, Newmont and Royal Gold.
Published:
These are five of the best stocks in a sector that has been humming along in what has been a turbulent year. They are all included on the Goldman Sachs Conviction List too.
Published:
Thursday's top analyst upgrades and downgrades included Carvana, Caterpillar, Dollar General, DraftKings, eBay, Facebook, Microsoft, Schlumberger, Spotify and Tesla.
Published:
Tuesday's top analyst upgrades and downgrades included AT&T, Cognex, Johnson & Johnson, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero Energy and Walt Disney.
Published:
Goldman Sachs analysts are bullish on these four top biotech stocks in front of first-quarter results. None of these companies is a proverbial one-trick pony, and they all are potential takeover...
Published:
Companies like IBM, Amazon, Western Digital and EA all posted big moves, some far more than what was expected, in Thursday's after-hours trading session for January 30, 2020.
Published:
Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.
Published:
Monday's top analyst upgrades, downgrades and initiations included Adobe, Amgen, Bank of America, Broadcom, CME, Goldman Sachs, Micron Technology, PepsiCo, UnitedHealth, Urban Outfitters and Vertex...
Published:
Tuesday's top analyst upgrades, downgrades and initiations included Albermarle, Amgen, Applied Materials, Biogen, CRISPR Therapeutics, CrowdStrike, CSX, Kroger, Slack, Teva Pharmaceutical and Xerox.
Published:
Tuesday's the top analyst upgrades, downgrades and initiations included Dropbox, Electronic Arts, Halliburton, Intuit, Juniper Networks, ProLogis, Silicon Motion, Taiwan Semiconductor, Textron and...
Published:
Credit Suisse and Merrill Lynch made calls in the biotech and pharmaceutical space last week, ahead of coming earnings reports.
Published:
Friday's top analyst upgrades, downgrades and initiations included Agilent Technologies, Alphabet, Altria, Amazon.com, Boeing, Caterpillar, Chipotle Mexican Grill, E*Trade, Gap, Snap and Twitter.
Published:
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, CSX, IBM, Netflix, Occidental Petroleum, Whiting Petroleum, Amgen, Gilead Sciences, Merck and Pfizer.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.